Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)

Clinical trial NCT03648333 · COMPLETED

Trial details

NCT number: NCT03648333
Sponsor: Hanlim Pharm. Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Male Subjects

Start date: 2013-12-01
Primary completion: 2014-02-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.